Cullinan Oncology Stock Target Price and Analyst Consensus
CGEM Stock | USD 23.46 0.52 2.17% |
The current analyst and expert consensus on Cullinan Oncology is Strong Buy, with 7 strong buy opinions. The current projected Cullinan Oncology target price consensus is 24.60 with 9 analyst opinions. The most common way Cullinan Oncology LLC analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Cullinan Oncology executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Cullinan Oncology. We strongly encourage you to use your own analysis of Cullinan Oncology LLC to validate this buy or sell advice. Cullinan Oncology buy-or-sell recommendation module provides average expert sentiment on the projected Cullinan Oncology LLC target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Cullinan Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 22.39 | Highest Forecast 27.31 | Target Price 24.6 |
Cullinan |
It's important to approach Cullinan Oncology's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Cullinan Oncology Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cullinan target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Cullinan Oncology's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
9 | Strong Buy |
Most Cullinan analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Cullinan stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Cullinan Oncology LLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationCullinan Oncology Target Price Projection
Cullinan Oncology's current and average target prices are 23.46 and 24.60, respectively. The current price of Cullinan Oncology is the price at which Cullinan Oncology LLC is currently trading. On the other hand, Cullinan Oncology's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Cullinan Oncology Market Quote on 21st of May 2024
Target Price
Analyst Consensus On Cullinan Oncology Target Price
Cullinan Oncology Analyst Ratings
Cullinan Oncology's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Cullinan Oncology stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Cullinan Oncology's financials, market performance, and future outlook by experienced professionals. Cullinan Oncology's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Cullinan Oncology price targets
Cullinan Oncology's stock target price is an estimate of its future price, usually made by analysts. Using Cullinan Oncology's target price to determine if it is a suitable investment can be done through the following steps:- Look at Cullinan Oncology's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Cullinan Oncology's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Cullinan Oncology Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cullinan Oncology is a key component of Cullinan Oncology valuation and have some predictive power on the future returns of a Cullinan Oncology.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cullinan Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Macroaxis Index Invested over 90 shares | ||
Check out Macroaxis Advice on Cullinan Oncology to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Cullinan Oncology LLC information on this page should be used as a complementary analysis to other Cullinan Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Cullinan Stock analysis
When running Cullinan Oncology's price analysis, check to measure Cullinan Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cullinan Oncology is operating at the current time. Most of Cullinan Oncology's value examination focuses on studying past and present price action to predict the probability of Cullinan Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cullinan Oncology's price. Additionally, you may evaluate how the addition of Cullinan Oncology to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Stocks Directory Find actively traded stocks across global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
The data published in Cullinan Oncology's official financial statements usually reflect Cullinan Oncology's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cullinan Oncology LLC. For example, before you start analyzing numbers published by Cullinan accountants, it's critical to develop an understanding of what Cullinan Oncology's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Cullinan Oncology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cullinan Oncology's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cullinan Oncology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cullinan Oncology LLC. Please utilize our Beneish M Score to check the likelihood of Cullinan Oncology's management manipulating its earnings.